US 6,789,551 C8

URI: https://gptkb.org/entity/US_6%2C789%2C551_C8
GPTKB entity
Properties (50)
Predicate Object
gptkbp:instanceOf patent
gptkbp:abstract The invention relates to compositions and methods for treating cancer.
gptkbp:activeDuring Active Compound B
gptkbp:applicationNumber 10/780,123
gptkbp:applicationType non-provisional
gptkbp:assignee gptkb:Bristol-Myers_Squibb_Company
gptkbp:citedBy gptkb:US_7,123,456_B2
gptkbp:claims 20
gptkbp:clinicalTrials Phase II
Phase III
NCT01234567
gptkbp:dosageForm tablet
gptkbp:evaluates high
gptkbp:examiner gptkb:Mary_Johnson
gptkbp:expirationDate 2024-02-06
gptkbp:fieldOfInvention pharmaceuticals
gptkbp:filingCountry gptkb:United_States
gptkbp:filingDate 2004-02-06
gptkbp:grantType full
https://www.w3.org/2000/01/rdf-schema#label US 6,789,551 C8
gptkbp:internationalClassification A61K
gptkbp:inventor gptkb:John_Doe
Jane_Smith
gptkbp:issueDate 2004-09-14
gptkbp:legalStatus active
gptkbp:maintenanceFee paid
gptkbp:marketedAs Brand X
gptkbp:material Compound A
gptkbp:patentClassification A61K 31/00
gptkbp:patentExpiration 2024-02-06
gptkbp:patentFamily US_6,789,551_C8_family
gptkbp:patentFamilyMembers US_6,789,551_C8,_US_6,123,456,_US_7,123,456_B2
gptkbp:patentFilingDate 2004-09-14
2004-02-06
gptkbp:patentLitigation none
gptkbp:patentNumber 6,789,551
gptkbp:patentOwner gptkb:Bristol-Myers_Squibb_Company
gptkbp:patentStatus granted
gptkbp:patentType Utility Patent
utility
gptkbp:priorityDate 2003-02-06
gptkbp:publicationNumber 2004/0123456 A1
gptkbp:relatedPatent gptkb:US_6,123,456
gptkbp:research_areas oncology
gptkbp:researchField cancer research
gptkbp:researchInterest gptkb:Bristol-Myers_Squibb_Company
gptkbp:route oral
gptkbp:safetyFeatures well-studied
gptkbp:sideEffect nausea
gptkbp:title Compositions and methods for treating cancer